Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapering Pace for Hypnotic Discontinuation
NCT02831894Phase 2Completed
- Sponsor
- National Jewish Health
- Start
- Nov 2015
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Insomnia (3 arms), sponsored by National Jewish Health. Primary endpoints: Hypnotic Discontinuation Rate at 20 weeks and Participant Dropout Rate at 20 weeks. Started Nov 2015; status: completed.
02
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02831894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02831894.